Hypovitaminosis D and hyperparathyroidism: a 5-year postoperative follow-up of 30,458 gastric bypass and sleeve gastrectomy patients

Katharina Stevens; Hella Hultin; Magnus Sundbom

doi:10.1016/j.soard.2024.02.004

Hypovitaminosis D and hyperparathyroidism: a 5-year postoperative follow-up of 30,458 gastric bypass and sleeve gastrectomy patients

Surg Obes Relat Dis. 2024 Feb 23:S1550-7289(24)00076-5. doi: 10.1016/j.soard.2024.02.004. Online ahead of print.

Authors

Katharina Stevens¹, Hella Hultin², Magnus Sundbom³

Affiliations

¹ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Electronic address: katharina.stevens@uu.se.
² Södersjukhuset Department of Surgery, Karolinska University, Stockholm Sweden.
³ Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

PMID: 38614927
DOI: 10.1016/j.soard.2024.02.004

Abstract

Background: Bariatric procedures are associated with nutrient deficiencies. Studies show an association between gastric bypass (Roux-en-Y gastric bypass [RYGB]) and hypovitaminosis D as well as hyperparathyroidism, yet few compare RYGB to sleeve gastrectomy (SG), and large long-term analyses are scarce.

Objective: Evaluate trends of vitamin D and parathyroid hormone (PTH) levels in RYGB and SG.

Setting: National quality register.

Method: The Scandinavian Obesity Surgery Registry records all bariatric surgeries in Sweden. Data from 2008 to 2021 on primary RYGB or SG with reported 25-hydroxy vitamin D (25-OH-D) and/or PTH levels were included. Individuals with an estimated glomerular filtration rate of <60 mL/min/1.73 m² were excluded, leaving a study population of 25,385 RYGB and 5073 SG patients.

Results: A decrease in 25-OH-D, mirrored by an increase in PTH, was observed after the first year for both procedures, but more pronounced in RYGB. At 5 years, 25-OH-D levels were still higher than at baseline. Regular supplementation resulted in better 25-OH-D and PTH levels. Linear regression found that procedure type (RYGB versus SG), 25-OH-D levels, and time since surgery were significant factors in predicting PTH levels. The risk of pathologic PTH levels (>7 pmol/L) at 2 and 5 years postoperatively was roughly three times higher in RYGB (odds ratios = 3.41 and 2.84, respectively).

Conclusions: Previous studies alongside these results suggest that RYGB, more so than SG, may cause hypovitaminosis D and thereby hyperparathyroidism, which could lead to osteopenia. The threshold for 25-OH-D should be >75 nmol/L, and despite higher levels, current vitamin D supplementation may not be sufficient. Follow-up should include screening for hyperparathyroidism and hypovitaminosis D.